12 West Capital Management’s Maravai LifeSciences MRVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$20.5M Sell
7,260,195
-1,661,140
-19% -$5.63M 3.47% 12
2025
Q4
$29M Sell
8,921,335
-3,600,000
-29% -$12.1M 3.45% 9
2025
Q3
$35.9M Hold
12,521,335
3.73% 8
2025
Q2
$30.2M Hold
12,521,335
3.19% 10
2025
Q1
$27.7M Buy
12,521,335
+930,000
+8% +$3.67M 4.08% 8
2024
Q4
$63.2M Sell
11,591,335
-2,419,844
-17% -$15.6M 6.62% 5
2024
Q3
$116M Buy
14,011,179
+800,000
+6% +$6.92M 11.91% 3
2024
Q2
$94.6M Buy
13,211,179
+8,191
+0.1% +$70.7K 9.72% 6
2024
Q1
$114M Buy
13,202,988
+1,600,000
+14% +$10.8M 10.42% 3
2023
Q4
$76M Buy
11,602,988
+5,139,877
+80% +$33.2M 7.17% 5
2023
Q3
$64.6M Buy
6,463,111
+3,101,275
+92% +$34.1M 5.85% 7
2023
Q2
$41.8M Buy
3,361,836
+793,066
+31% +$10.7M 3.59% 14
2023
Q1
$36M Buy
+2,568,770
New +$36.9M 3.09% 11

Other funds holding MRVI